GS
LABU icon

GTS Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

GTS Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,740
Closed -$2.67M – 2790
2024
Q3 		$2.67M Sell
20,740
-9,100
-30% -$1.19M 0.01% 1350
2024
Q2 		$3.39M Buy
29,840
+4,335
+17% +$464K 0.01% 1120
2024
Q1 		$3.39M Sell
25,505
-13,450
-35% -$1.76M 0.01% 1118
2023
Q4 		$4.75M Buy
38,955
+27,630
+244% +$2.11M 0.01% 1040
2023
Q3 		$863K Buy
+11,325
New +$1.16M ﹤0.01% 2128

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

GTS Securities's LABU Position: Q1 2026 in Review

GTS Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 10,466 shares — an estimated $1.67M sold.

GTS Securities first reported a position in LABU in Q2 2023 and held it in 9 quarters. The position peaked at $6.09M in Q3 2024. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • GTS Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 10,466 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $1.67M.
  • GTS Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and held it in 9 quarters.
  • GTS Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $6.09M in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.